Compare MD & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MD | BHVN |
|---|---|---|
| Founded | 1979 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 1996 | 2022 |
| Metric | MD | BHVN |
|---|---|---|
| Price | $25.91 | $13.31 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 14 |
| Target Price | $20.50 | ★ $29.08 |
| AVG Volume (30 Days) | 638.9K | ★ 3.4M |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 263.03 | 26.08 |
| EPS | ★ 0.85 | N/A |
| Revenue | ★ $1,913,849,000.00 | N/A |
| Revenue This Year | $3.72 | N/A |
| Revenue Next Year | $2.62 | N/A |
| P/E Ratio | $31.21 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.70 | $7.48 |
| 52 Week High | $28.86 | $18.57 |
| Indicator | MD | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 36.40 |
| Support Level | $25.24 | $8.75 |
| Resistance Level | $27.23 | $13.54 |
| Average True Range (ATR) | 0.79 | 0.99 |
| MACD | -0.04 | -0.39 |
| Stochastic Oscillator | 53.81 | 6.09 |
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.